medRxiv

This working paper compares the incidence of COVID-19 Omicron infection in the Qatari cohort of adolescents 12 years of age who received the two-dose primary series of the 30-µg BNT162b2 vaccine to that in the Qatari cohort of adolescents 11 years of age who received the two-dose primary-series of the pediatric 10-µg BNT162b2 vaccine.

Working Paper